The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer's disease presents a significant public health challenge,…
CertaraApril 29, 2024
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin
Physiologically-based pharmacokinetic models combine knowledge about physiology, drug product properties, such as physicochemical parameters, absorption,…
CertaraApril 26, 2024
Explore the World of Endogenous Biomarkers with Simcyp™!
Endogenous biomarkers play a pivotal role in comprehending drug-body interactions, shaping drug development, and propelling…
CertaraApril 26, 2024
Why are Clinical Data Standards Essential for EDC and Non-EDC Data?
Clinical data standards are essential for both EDC & non-EDC data. Learn how study build…
CertaraApril 25, 2024
Latest PBPK Modeling Platform Advances Drug Development
In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science…
CertaraApril 23, 2024
Pinnacle 21 Releases New PMDA, FDA, NMPA Validation Engines
Pinnacle 21 by Certara announces the latest Validation Engines for submissions to Japan PMDA, US…
CertaraApril 23, 2024
